Literature DB >> 20171694

Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?

Benjamin N Breyer1, Alan W Shindel, Yun-Ching Huang, Michael L Eisenberg, Dana A Weiss, Tom F Lue, James F Smith.   

Abstract

PURPOSE: Traditionally, diagnosis and treatment plans for Peyronie's disease have been based on history and physical examination. Penile ultrasound provides rapid, anatomical information to establish disease severity, and to monitor progression and response to medical therapy. We determined the relationship between ultrasound characteristics and progression to surgical intervention in men with Peyronie's disease.
MATERIALS AND METHODS: We conducted a retrospective cohort study of 518 patients with Peyronie's disease. Patients completed a Peyronie's disease specific questionnaire detailing medical history, health related behaviors and Peyronie's disease characteristics, and underwent sonographic evaluation of the penis. Measurements of subtunical calcifications, septal fibrosis, tunical thickening (tunica thickness greater than 2 mm) and intracavernous fibrosis were made. Progression to surgery was determined from the medical record.
RESULTS: In this cohort (mean patient age 53.8 years, range 20 to 78) 31% of patients had calcifications, 50% had tunical thickening, 20% had septal fibrosis and 15% had intracavernous fibrosis. Overall 25% of the cohort progressed to surgical intervention after an average followup of 1.25 years (range 0 to 7.6). Patients who underwent surgery were more likely to have subtunical calcifications present at the first clinic visit (OR 1.75, 95% CI 1.16-2.62). No other sonographic characteristics were associated with progression to surgery. After adjustment for age, marital status, degree of curvature, additional penile deformity, difficulty with penetration, ability to have intercourse and prior treatment for Peyronie's disease, calcifications were strongly associated with progression to surgery (OR 2.75, 95% CI 1.25-3.45).
CONCLUSIONS: In a large cohort of patients with Peyronie's disease the presence of sonographically detected sub-tunical calcifications during the initial office evaluation was independently associated with subsequent surgical intervention. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171694      PMCID: PMC3565595          DOI: 10.1016/j.juro.2009.12.026

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  Peyronie's disease: etiology, epidemiology and medical treatment.

Authors:  Jason M Greenfield; Laurence A Levine
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

Review 2.  Ultrasound in patients affected with Peyronie's disease.

Authors:  P Fornara; H-P Gerbershagen
Journal:  World J Urol       Date:  2004-07-28       Impact factor: 4.226

3.  Duplex ultrasonography detects clinically significant anomalies of penile arterial vasculature affecting surgical approach to penile straightening.

Authors:  Edward M Schaeffer; Jonathan P Jarow; Joseph Vrablic; Jonathan P Jarow
Journal:  Urology       Date:  2006-01       Impact factor: 2.649

4.  An ultrasonographic study of Peyronie's disease.

Authors:  S Muralidhar; M Gulati; B Kumar; S K Sharma; K Suman; P B Roy
Journal:  Australas Radiol       Date:  1996-05

5.  The anatomy of the tunica albuginea in the normal penis and Peyronie's disease.

Authors:  G Brock; G L Hsu; L Nunes; B von Heyden; T F Lue
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

6.  Proposal: trauma as the cause of the Peyronie's lesion.

Authors:  C J Devine; K D Somers; S G Jordan; S M Schlossberg
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

7.  Diagnostic value of magnetic resonance imaging in Peyronie's disease--a comparison both with palpation and ultrasound in the evaluation of plaque formation.

Authors:  Ekkehard W Hauck; Nils Hackstein; Rolf Vosshenrich; Thorsten Diemer; Hans U Schmelz; Thomas Bschleipfer; Immo Schroeder-Printzen; Wolfgang Weidner
Journal:  Eur Urol       Date:  2003-03       Impact factor: 20.096

8.  An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression.

Authors:  A I El-Sakka; H M Hassoba; R M Chui; R S Bhatnagar; R Dahiya; T F Lue
Journal:  J Urol       Date:  1997-12       Impact factor: 7.450

9.  Penile sonographic and clinical characteristics in men with Peyronie's disease.

Authors:  James F Smith; William O Brant; Vincent Fradet; Alan W Shindel; Eric Vittinghoff; Thomas Chi; Yun-Ching Huang; Cole B Davis; Simon Conti; Tom F Lue
Journal:  J Sex Med       Date:  2009-08-28       Impact factor: 3.802

10.  Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.

Authors:  John P Mulhall; Steven D Creech; Stephen A Boorjian; Sam Ghaly; Edward D Kim; Ayham Moty; Rodney Davis; Wayne Hellstrom
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

View more
  5 in total

1.  Peyronie's Disease: Nonsurgical Therapy Options.

Authors:  Franklin E Kuehhas; Peter Weibl; Tosev Georgi; Nenad Djakovic; Ralf Herwig
Journal:  Rev Urol       Date:  2011

2.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

Review 3.  All about Peyronie's disease.

Authors:  Ahmed A Hussein; Amjad Alwaal; Tom F Lue
Journal:  Asian J Urol       Date:  2015-04-16

4.  Ultrasound on Erect Penis Improves Plaque Identification in Patients With Peyronie's Disease.

Authors:  Yu Liu; Dequan Zheng; Xiaolin Liu; Xiaohong Shi; Shengchun Shu; Jinbing Li
Journal:  Front Pharmacol       Date:  2019-04-04       Impact factor: 5.810

Review 5.  Collagenase Clostridium histolyticum in the treatment of Peyronie's disease: patient selection and perspectives.

Authors:  Paige K Kuhlmann; Kenneth J DeLay; James Anaissie; Wayne Jg Hellstrom; Faysal A Yafi
Journal:  Patient Prefer Adherence       Date:  2017-03-02       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.